Research Groups

Section of Molecular Pathology

Previous Publications - All Publications 2017-2013

1. Wang Q., Satomi K., Oh J. E., Hutter B., Brors B., Diessl N., Liu H. K., Wolf S., Wiestler O., Kleihues P., Koelsch B., Kindler-Rohrborn A., Ohgaki H. (2016) Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea Am J Pathol; 186(10):2569-76. PMID: 27658714

2. Zhao F., Ohgaki H., Xu L., Giangaspero F., Li C., Li P., Yang Z., Wang B., Wang X., Wang Z., Ai L., Zhang J., Luo L., Liu P. (2016) Molecular subgroups of adult medulloblastoma: a long-term single-institution study Neuro Oncol; 18(7):982-90. PMID: 27106407

3. Oh J. E., Ohta T., Nonoguchi N., Satomi K., Capper D., Pierscianek D., Sure U., Vital A., Paulus W., Mittelbronn M., Antonelli M., Kleihues P., Giangaspero F., Ohgaki H. (2016) Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma Brain Pathol; 26(4):517-22. PMID: 26443480

4. Gramatzki D., Dehler S., Rushing E. J., Zaugg K., Hofer S., Yonekawa Y., Bertalanffy H., Valavanis A., Korol D., Rohrmann S., Pless M., Oberle J., Roth P., Ohgaki H., Weller M. (2016) Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009 Cancer; 122(14):2206-15. PMID: 27088883

5. Louis D. N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W. K., Ohgaki H., Wiestler O. D., Kleihues P., Ellison D. W. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary Acta Neuropathol; 131(6):803-20. PMID: 27157931

6. Stewart B. W., Bray F., Forman D., Ohgaki H., Straif K., Ullrich A., Wild C. P. (2016) Cancer prevention as part of precision medicine: 'plenty to be done' Carcinogenesis; 37(1):2-9. PMID: 26590901

7. Parroche P., Roblot G., Le Calvez-Kelm F., Tout I., Marotel M., Malfroy M., Durand G., McKay J., Ainouze M., Carreira C., Allatif O., Traverse-Glehen A., Mendiola M., Pozo-Kreilinger J. J., Caux C., Tommasino M., Goutagny N., Hasan U. A. (2016) TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression Oncogenesis; 5(7):e244. PMID: 27454079

8. Walsh K. M., Ohgaki H., Wrensch M. R. (2016) Epidemiology Handb Clin Neurol; 3-18. PMID: 26948345

9. Oh J.E., Ohta T., Satomi K., Foll M., Durand G., McKay J., Le Calvez-Kelm F., Mittelbronn M., Brokinkel B., Paulus W., Ohgaki H. (2015) Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas J Neuropathol. Exp. Neurol; 74(10):952-959. PMID: 26360373

10. Baumgarten P., Harter P.N., Tonjes M., Capper D., Blank A.E., Sahm F., von Deimling A., Kolluru V., Schwamb B., Rabenhorst U., Starzetz T., Kogel D., Rieker R.J., Plate K.H., Ohgaki H., Radlwimmer B., Zornig M., Mittelbronn M. (2014) Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity Neuropathol. Appl. Neurobiol; 40(2):205-216.

11. Gheit T., Abedi-Ardekani B., Carreira C., Missad C.G., Tommasino M., Torrente M.C. (2014) Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma J Med Virol; 86(4):642-646.

12. Fiaschetti G., Abela L., Nonoguchi N., Dubuc A.M., Remke M., Boro A., Grunder E., Siler U., Ohgaki H., Taylor M.D., Baumgartner M., Shalaby T., Grotzer M.A. (2014) Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma Br J Cancer; 110(3):636-647.

13. Ohgaki H., Burger P., Kleihues P. (2014) Definition of primary and secondary glioblastoma--response Clin Cancer Res; 20(7):2013.

14. Kim Y.H., Ohta T., Oh J.E., Le Calvez-Kelm F., McKay J., Voegele C., Durand G., Mittelbronn M., Kleihues P., Paulus W., Ohgaki H. (2014) TP53, MSH4, and LATS1 Germline Mutations in a Family with Clustering of Nervous System Tumors Am J Pathol; 184(9):2374-2381.

15. Ohta T., Kim Y.H., Oh J.E., Satomi K., Nonoguchi N., Keyvani K., Pierscianek D., Sure U., Mittelbronn M., Paulus W., Vital A., Yokoo H., McDonald K., Kleihues P., Nazaret N., Barbet F., Lachuer J., Ohgaki H. (2014) Alterations of the RRAS and ERCC1 Genes at 19q13 in Gemistocytic Astrocytomas J Neuropathol Exp Neurol; 73(10):908-915.

16. Suzuki A., Nobusawa S., Natsume A., Suzuki H., Kim Y.H., Yokoo H., Nagaishi M., Ikota H., Nakazawa T., Wakabayashi T., Ohgaki H., Nakazato Y. (2014) Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas J Neurooncol; 120(2):283-291.

17. Louis D.N., Perry A., Burger P., Ellison D.W., Reifenberger G., von Deimling A., Aldape K., Brat D., Collins V.P., Eberhart C., Figarella-Branger D., Fuller G.N., Giangaspero F., Giannini C., Hawkins C., Kleihues P., Korshunov A., Kros J.M., Beatriz Lopes M., Ng H.K., Ohgaki H., Paulus W., Pietsch T., Rosenblum M., Rushing E., Soylemezoglu F., Wiestler O., Wesseling P. (2014) International society of neuropathology-haarlem consensus guidelines for nervous system tumor classification and grading Brain Pathol; 24(5):429-435.

18. Xu Q.F., Pan Y.W., Li L.C., Zhou Z., Huang Q.L., Pang J.C., Zhu X.P., Ren Y., Yang H., Ohgaki H., Lv S.Q. (2014) MiR-22 is Frequently Downregulated in Medulloblastomas and Inhibits Cell Proliferation via the Novel Target PAPST1 Brain Pathol; 24(6):568-583.

19. Corbex M., Bouzbid S., Traverse-Glehen A., Aouras H., McKay-Chopin S., Carreira C., Lankar A., Tommasino M., Gheit T. (2014) Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors PLoS ONE; 9(12):e114559.

20. Peng C., Deng Q., Li Z., Xiong C., Li C., Zheng F. (2014) Risk-Association of DNMT1 Gene Polymorphisms with Coronary Artery Disease in Chinese Han Population Int J Mol Sci; 15(12):22694-22705.

21. Motomura K., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Nakazato Y., Tanaka Y., Nonoguchi N., Pierscianek D., Kim Y.H., Mariani L., Vital A., Perry A., Ohgaki H. (2013) PDGFRA gain in low-grade diffuse gliomas J Neuropathol Exp Neurol; 72(1):61-66.

22. Pierscianek D., Kim Y.H., Motomura K., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Wrede K., Nakazato Y., Tanaka Y., Mariani L., Vital A., Sure U., Ohgaki H. (2013) MET gain in diffuse astrocytomas is associated with poorer outcome Brain Pathol; 23(1):13-18.

23. Nonoguchi N., Ohta T., Oh J.E., Kim Y.H., Kleihues P., Ohgaki H. (2013) TERT promoter mutations in primary and secondary glioblastomas Acta Neuropathol; 126(6):931-937.

24. Ohgaki H., Kleihues P. (2013) The definition of primary and secondary glioblastoma Clin Cancer Res; 19(4):764-772.

25. Sasaki A., Yokoo H., Tanaka Y., Homma T., Nakazato Y., Ohgaki H. (2013) Characterization of microglia/macrophages in gliomas developed in S-100beta-v-erbB transgenic rats Neuropathology; 33(5):505-514.

26. Wozniak M.B., Le Calvez-Kelm F., Abedi-Ardekani B., Byrnes G., Durand G., Carreira C., Michelon J., Janout V., Holcatova I., Foretova L., Brisuda A., Lesueur F., McKay J., Brennan P., Scelo G. (2013) Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the United States PLoS. One; 8(3):e57886.

27. Ohgaki H. (2013) Contribution of Molecular Biology to the Classification of Low-Grade Diffuse Glioma ; 61-72.